These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 30703438)
1. Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic? Anderson WC; Szefler SJ Ann Allergy Asthma Immunol; 2019 Apr; 122(4):367-372. PubMed ID: 30703438 [TBL] [Abstract][Full Text] [Related]
2. Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Reibman J; Tan L; Ambrose C; Chung Y; Desai P; Llanos JP; Moynihan M; Tkacz J Ann Allergy Asthma Immunol; 2021 Sep; 127(3):318-325.e2. PubMed ID: 33775904 [TBL] [Abstract][Full Text] [Related]
3. Asthma biologics: Comparing trial designs, patient cohorts and study results. Doroudchi A; Pathria M; Modena BD Ann Allergy Asthma Immunol; 2020 Jan; 124(1):44-56. PubMed ID: 31655122 [TBL] [Abstract][Full Text] [Related]
4. Pediatric Severe Asthma in the Era of Biologic Treatments. Teague WG Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):118-120. PubMed ID: 32953228 [No Abstract] [Full Text] [Related]
5. Asthma biologics: Real-world effectiveness, impact of switching biologics, and predictors of response. Abbas F; Georas S; Cai X; Khurana S Ann Allergy Asthma Immunol; 2021 Dec; 127(6):655-660.e1. PubMed ID: 34481992 [TBL] [Abstract][Full Text] [Related]
7. Severe asthma and biologics: Data are good, listening to patients is better. Bukstein DA; Guerra DG Ann Allergy Asthma Immunol; 2021 Sep; 127(3):285-286. PubMed ID: 34479728 [No Abstract] [Full Text] [Related]
8. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272 [TBL] [Abstract][Full Text] [Related]
9. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [TBL] [Abstract][Full Text] [Related]
10. Role of Biologics in Asthma. McGregor MC; Krings JG; Nair P; Castro M Am J Respir Crit Care Med; 2019 Feb; 199(4):433-445. PubMed ID: 30525902 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations. McQueen RB; Sheehan DN; Whittington MD; van Boven JFM; Campbell JD Pharmacoeconomics; 2018 Aug; 36(8):957-971. PubMed ID: 29736895 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of biologics for asthma treatment by allergy specialists: A questionnaire survey. Kuruvilla M; Ariue B; Oppenheimer JJ; Singh U; Bernstein JA Ann Allergy Asthma Immunol; 2020 Oct; 125(4):433-439. PubMed ID: 32629016 [TBL] [Abstract][Full Text] [Related]
13. How to compare the efficacy of biologic agents in asthma. Viswanathan RK; Busse WW Ann Allergy Asthma Immunol; 2020 Aug; 125(2):137-149. PubMed ID: 32387169 [TBL] [Abstract][Full Text] [Related]
14. Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Bermejo I; Stevenson M; Cooper K; Harnan S; Hamilton J; Clowes M; Carroll C; Harrison T; Saha S Pharmacoeconomics; 2018 Feb; 36(2):131-144. PubMed ID: 28933002 [TBL] [Abstract][Full Text] [Related]
15. Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma. Moore WC; Panettieri RA; Trevor J; Ledford DK; Lugogo N; Soong W; Chipps BE; Carr W; Belton L; Gandhi H; Trudo F; Ambrose CS Ann Allergy Asthma Immunol; 2020 Sep; 125(3):294-303.e1. PubMed ID: 32304877 [TBL] [Abstract][Full Text] [Related]
16. The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma. Tice JA; Campbell JD; Synnott PG; Walsh JME; Kumar VM; Whittington M; Adair E; Rind D; Pearson SD J Manag Care Spec Pharm; 2019 May; 25(5):510-514. PubMed ID: 31039065 [TBL] [Abstract][Full Text] [Related]
17. The use of biologic therapies for the management of pediatric asthma. Lovinsky-Desir S Pediatr Pulmonol; 2020 Mar; 55(3):803-808. PubMed ID: 31880870 [TBL] [Abstract][Full Text] [Related]
18. How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit. Pepper AN; Hanania NA; Humbert M; Casale TB J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1081-1088. PubMed ID: 33685606 [TBL] [Abstract][Full Text] [Related]
19. ICER Can Do Better for Patients. Mendez K J Manag Care Spec Pharm; 2019 May; 25(5):514-516. PubMed ID: 31039068 [TBL] [Abstract][Full Text] [Related]
20. Long-term safety, durability of response, cessation and switching of biologics. Mohan A; Qiu AY; Lugogo N Curr Opin Pulm Med; 2024 May; 30(3):303-312. PubMed ID: 38426355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]